Results 161 to 170 of about 264,257 (370)
EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP [PDF]
Li Jiao +11 more
openalex +1 more source
The Notch signaling pathway plays a dual role in cancer, acting as both a tumor promoter and suppressor depending on cellular context. This review highlights how natural products modulate Notch signaling to inhibit tumor initiation, progression, angiogenesis, and cancer stem cell maintenance.
Rabab Fatima +15 more
wiley +1 more source
Pathophysiology and molecular aspects of diffuse large B-cell lymphoma
Diffuse large B-Cell lymphoma is the most common subtype of non-Hodgkin lymphoma in the West. In Brazil, it is the fifth cause of cancer, with more than 55,000 cases and 26,000 deaths per year.
Gisele Rodrigues Gouveia +2 more
doaj
Background Autoimmune hemolytic anemia-associated diffuse large B cell lymphoma is rare, with distinct pathogenic mechanisms and therapeutic responses in cold agglutinin syndrome (CAS) and warm autoimmune hemolytic anemia subtypes poorly characterized ...
Zhiye Zhang +3 more
doaj +1 more source
Non-Hodgkin’s Lymphoma of the Uterine Cervix [PDF]
Non Hodgkin’s Lymphoma (NHL) causes many deaths worldwide and its incidence is increasing. They occur commonly in middle aged and elderly people and are disseminated at diagnosis.
Kaler, AK, Vasudev, DS
core
Evolution in the Definition of Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: A Model for the Future of Personalized Medicine [PDF]
Elaine S. Jaffe, Antonino Carbone
openalex +1 more source
False‐negative
Hugo J.A. Adams +5 more
openalex +1 more source
Pheochromocytoma and Diffuse Large B‐Cell Lymphoma in the Ipsilateral Adrenal Gland: A Case Report
ABSTRACT Introduction Pheochromocytoma is a catecholamine‐producing tumor arising from the adrenal medulla. When it coexists with a tumor of different origin within the same adrenal gland, it is classified as a collision tumor involving a pheochromocytoma.
Ken Maekawa +9 more
wiley +1 more source
Homoharringtonine (HHT), a clinically approved anti‐leukemic drug, directly binds the RNA‐binding protein EWSR1. HHT induces an allosteric conformational switch in the RNA recognition motif of EWSR1, driving self‐association and liquid–liquid phase separation (LLPS). The resulting condensates act as regulatory hubs that sequester the m6A reader YTHDF2,
Ting‐Ting Liu +17 more
wiley +1 more source

